Exosomal Small RNA and miRNA Sequencing Service
Exosomes serve as an important medium for intercellular communication, and the small RNAs/miRNAs they carry play a key role in the onset and progression of diseases. Creative Biostructure's exosomal small RNA/miRNA sequencing service employs high-throughput sequencing technology to precisely profile miRNAs and other small RNAs within exosomes, enabling comprehensive characterization of their regulatory roles in both biological and pathological processes.
What Are Exosomal miRNAs and Why Study Them as Biomarkers?
Small RNAs serve as core regulatory factors in biological processes, participating in gene expression regulation, RNA processing and splicing, protein translation, immune defense, and gametogenesis. Among these, microRNAs (miRNAs) are central members of the small RNA family, precisely targeting mRNAs to achieve fine-tuned regulation of gene expression at the post-transcriptional level.
Exosomal miRNAs are closely associated with cancers, cardiovascular diseases, and immune system disorders. The miRNAs carried by exosomes not only remotely regulate recipient cells (e.g., by creating a suitable microenvironment for cancer cell metastasis) but also serve as highly valuable liquid biopsy biomarkers, demonstrating revolutionary potential in early disease diagnosis, drug efficacy evaluation, personalized treatment plan formulation, and prognosis monitoring.
Figure 1. Functions of exosomal miRNAs in cancer. (Li C, Zhou, et al., 2022)
Our Exosomal miRNA and Small RNA Sequencing Service
Creative Biostructure delivers comprehensive exosomal small RNA/miRNA sequencing services by integrating cutting-edge sequencing technologies with holistic bioinformatics analysis. Our professional services, which span the entire process from sample processing to data analysis, assist customers with their scientific research. We are able to support a range of sample types and provide customized analysis services to meet different research needs.
Our services include:
| Key Services | Description |
|---|---|
| Exosome Sample Processing |
|
| High-throughput Sequencing Analysis | Leveraging Illumina platforms (e.g., HiSeq, NovaSeq) with combined RNA sequencing and small RNA sequencing technologies, we deliver high-resolution and high-sensitivity sequencing data. |
| Bioinformatics Analysis | We offer comprehensive data analysis services ranging from basic analysis to advanced functional annotation, exploring the biological significance and potential applications of exosomal small RNAs. |
Workflow for Exosomal Small RNA and miRNA Analysis
From sample receipt to data analysis, Creative Biostructure follows standardized procedures to ensure experimental quality and result reliability. Our standard workflow includes the following key steps:
Sample Receipt and Evaluation
Client samples are received, followed by visual inspection, quantity verification, and preliminary quality assessment to ensure compliance with experimental specifications.
Exosome Separation and Purification
Separate exosomes using ultracentrifugation combined with density gradient centrifugation, and verify exosome characteristics through nanoparticle tracking analysis (NTA) and Western blot.
RNA Extraction and Quality Control
Total RNA is extracted from exosomes using dedicated isolation kits, with RNA quality assessed to ensure integrity.
Library Preparation and Sequencing
Sequencing libraries are constructed from small RNAs, subjected to rigorous quality control, and subsequently sequenced on Illumina platforms to ensure sufficient sequencing depth.
Data Analysis and Reporting
We perform data quality control, sequence alignment, expression quantification, differential analysis, target gene prediction, and functional enrichment analysis, generating a detailed data analysis report.
Figure 2. Exosomal Small RNA and miRNA Sequencing Project Workflow. (Creative Biostructure)
Sample Guide
Learn about the types of samples we support and submission requirements to ensure your samples meet laboratory standards.
| Supported sample types | Sample submission requirements |
|---|---|
|
|
Deliverables
Upon completion of the service, you will receive:
- Raw data
- Raw sequencing data (FASTQ format)
- Experimental process records and quality control reports
- Raw data MD5 verification files
- Data quality analysis report
- Small RNA sequence alignment and annotation results
- Expression matrix and differential analysis results
- Target gene prediction and functional enrichment analysis
- Explanation of experimental procedures and analytical methods
- Visualization charts of all analytical results
- Interpretation and discussion of biological significance
- Complete PDF analysis report
Advantages of Our Exosomal Small RNA and miRNA Sequencing Service
- High-Purity Exosome Isolation:Employing multi-step purification procedures combined with diverse exosome validation methods to ensure high-purity, high-activity exosomes, providing a reliable sample foundation for downstream analysis.
- Ultra-Sensitive Detection:Optimized extraction and library construction protocols for low-abundance RNAs in exosomes, enabling efficient capture and accurate quantification of trace miRNAs.
- Professional Bioinformatics Analysis:Our experienced bioinformatics team provides comprehensive data analysis services, spanning basic processing to advanced functional annotation, to deeply explore biological significance.
- Stringent Quality Control:Implementation of rigorous QC standards throughout the process, with quality checks at every experimental step to ensure publication-ready data quality and reproducible results.
- Flexible Service Solutions:Customizable service packages tailored to client needs, spanning sample preprocessing to in-depth data analysis, addressing diverse requirements across research stages.
- Rapid Turnaround Time:Optimized experimental workflows and efficient data analysis pipelines ensure high-quality results delivered in the shortest timeframe to accelerate your research progress.
Case Study
Case: Identification of Serum Exosomal miRNAs as Early Diagnostic Biomarkers for Non-Small Cell Lung Cancer (NSCLC)
Background
To investigate the feasibility of early diagnosis in small cell lung cancer (SCLC), this study analyzed serum-derived exosomal microRNAs (miRNAs) from SCLC patients, aiming to ultimately improve prognosis.
Research Highlights
- Comprehensive screening of differential miRNAs in serum exosomes of lung cancer patients using high-throughput sequencing technology.
- The diagnostic value of 3 miRNAs was confirmed by qRT-PCR validation and expanded sample size assay.
- Functional enrichment analysis showed that these miRNAs were mainly involved in cell proliferation, apoptosis and metastasis-related pathways.
Conclusion
Figure 3. Identification of exosomal microRNA (miRNA) expression profiles in patients with SCLC. (Kim D H, et al., 2023)
Seven differentially expressed miRNAs were identified by small RNA sequencing of serum exosomes from non-small cell lung cancer patients and healthy controls. among them, the combination of miR-200b-3p, miR-3124-5p, and miR-92b-5p could be used as a diagnostic and prognostic biomarker of non-small cell lung cancer, with an AUC value of 0.93.
At Creative Biostructure, our exosome small RNA/miRNA deep sequencing service offers an end-to-end solution, encompassing exosome isolation, RNA enrichment, and RNA sequencing. Whether you need details about the service, a quotation, or have any technical questions, our expert team will provide timely and professional support. Contact us today to discuss your project and receive a personalized solution.
References
- Li C, Zhou T, Chen J, et al. The role of Exosomal miRNAs in cancer. Journal of translational medicine, 2022, 20(1): 6.
- Kim D H, Park H, Choi Y J, et al. Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer. Biomarker Research, 2023, 11(1): 80.
Frequently Asked Questions
For any inquiries, our support team is ready to help you get technical support for your research and maximize your experience with Creative Biostructure.